Christopher Warlick, M.D.

Dr. Christopher Warlick is an Assistant Professor in Urology and treats several urologic cancers, with an emphasis on prostate cancer. Dr. Warlick has a busy prostate cancer practice and is a nationally recognized leader on Active Surveillance for low risk prostate cancer, while performing robotic-assisted laparoscopic radical prostatectomies for men requiring definitive therapy. Dr. Warlick has ongoing research focusing on the use of MR imaging in prostate cancer, the development of novel tests to help determine early
signs of disease progression, and on programs to increase the use of shared decision making around PSA screening and prostate cancer treatment decision making.
 

Medical School Residency

Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, Klotz LH, Warlick CA, Holmberg L, Bailey DE Jr, Wallace ME, Kantoff PW, Carroll PR. Active surveillance for early-stage prostate cancer: review of the current literature. Cancer 112:1650-1659, 2008.

Berkowitz J, WarlickC, North A, Gearhart JP.  Duplicate bladder exstrophy with complete duplication of müllerian structures.  Urology 70:811.e15-17, 2007.

Carter HB, KettermannA, Warlick C, Metter EJ, Landis P, Walsh PC, Epstein Jl.  Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience. J Urology. 178:2359-2364, 2007.

Permpongkosol S, Lima GC, Warlick CA, Allaf ME, Varkarakis IM, Bagga HS, Kohanim S, Kavoussi LR. Sostchemotherapy laparoscopic retroperitoneal lymph node dissection: evaluation of complications. Urology 69:361-365, 2007.

Warlick CA, Mouli SK, Allaf ME, Wagner AA, Kavoussi LR, Bladder irrigation using hydrogen peroxide for clot evacuation. Urology 68:1331-1332, 2006.

Medical School Residency